Infectious disease surveillance updateDengue and dengue vectors in the WHO European region: past, present, and scenarios for the futureAutochthonous dengue emphasises the threat of arbovirosis in EuropeChikungunya, an epidemic arbovirosisDetection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case studyEmerging infections: a perpetual challengeGlobal warming and malaria: a call for accuracyCombination implementation for HIV prevention: moving from clinical trial evidence to population-level effectsEmergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological studyArtemisinin combination therapy for vivax malariaCongenital Zika syndrome in Brazil.The Xs and Y of immune responses to viral vaccinesZika virus in semen of a patient returning from a non-epidemic areaZika virus in the female genital tractAn international registry for women exposed to Zika virus during pregnancy: time for answers.New data back early hypothesis for infectious microcephaly.Potential for Zika virus introduction and transmission in resource-limited countries in Africa and the Asia-Pacific region: a modelling studyChallenges and key research questions for yaws eradicationEmerging tick-borne infections in mainland China: an increasing public health threatPre-entry screening programmes for tuberculosis in migrants to low-incidence countries: a systematic review and meta-analysisA review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium.Rickettsia felis: the next mosquito-borne outbreak?Surgical treatment of drug-resistant tuberculosisMitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systemsPredictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysisCrowd and environmental management during mass gatheringsZika virus: history of a newly emerging arbovirusPerinatally acquired HIV infection in adolescents from sub-Saharan Africa: a review of emerging challengesCrimean-Congo haemorrhagic feverGlobal epidemiology of hepatitis C virus infectionGenetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association studyEmergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological studyPopulation-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysisThe development of global vaccine stockpilesWhat does epidemiology tell us about risk factors for herpes zoster?Spread of yellow fever virus outbreak in Angola and the Democratic Republic of the Congo 2015–16: a modelling studyEpidemic arboviral diseases: priorities for research and public healthThe development of Lapdap, an affordable new treatment for malariaEffect of washing hands with soap on diarrhoea risk in the community: a systematic reviewFollowing in Soper's footsteps: northeast Brazil 63 years after eradication of Anopheles gambiae
P1433
P3919
Zika virus in the dock.Zika virus at the games: is it safe?One decade on.Vaccine against Zika virus must remain a priority.Managing tuberculosis and all its friends.The Lancet Infectious Diseases--the state of play.Lessons from polio to Ebola.Rationality and coordination for Ebola outbreak in west Africa.Ebola PHEIC is over but emergency continues.A wake-up call for polio eradication.The case for vaccinating against meningitis B.Need for global cooperation in control of MERS-CoV.Coordination essential in malaria battle.Measles immunisation: time to close the gap.The challenge of HIV associated neurocognitive disorder.2018 must be the final target for polio eradication.Antimicrobial resistance: the Hydra among us.A proportionate response to H7N9.Progress in tackling malaria.Antibiotic resistance: long-term solutions require action now.Guinea worm disease nears eradication.A new day for African public health.Concerns raised over water quality at the Rio Olympics.Securing gains against malaria in uncertain times.Is malaria elimination within reach?MERS--an uncertain future.A proper place for retraction.Toxoplasma gondii: an unknown quantity.Climate change: the role of the infectious disease community.The imperative of vaccination.The dengue vaccine dilemma.Between the devil and the deep blue sea.An enduring reminder of the importance of public health.Viral hepatitis: setting sights on the right target.Enterovirus D68: the unexpected guest.Time to take sexually transmitted infections seriously.Time for global political action on antimicrobial resistance.Yellow fever: the consequences of neglect.Tuberculosis reaches new milestones, good and bad.Breaking up is hard to do: Brexit and European science.
P50
Q24247186-37A11766-C965-4ADC-AFD3-65D3BF3FC278Q24290837-62485E9F-2D88-40B6-9490-F37AA94CD137Q24290839-AC6A021F-A728-4D37-94B9-FE79DB863E9BQ24291001-C59DB4F6-902A-4A68-B316-127BFC31AC52Q24311332-0149FBF7-9844-495C-AD2B-F23FD387D42CQ24514431-480B7E85-F6E6-4C18-A6EA-3FE4655486ACQ24597614-3C4F090D-990A-4A9D-880C-A746B61BE1CEQ24610019-57A97C7E-7CFE-434A-B9C4-EE03B9B68C58Q24617818-FE203080-9BC9-449F-B48E-68D3B92AF306Q24622539-8C9CA6C9-49CB-4C76-8AC0-DAC47CB7EA65Q24705194-FFD50812-6E2A-44BA-9814-509346398EBCQ24706476-02F4B0D7-5C1B-44B9-BF04-7F13A8CAE887Q26247138-B314FBE2-96B6-490F-BBC8-D0C9D9B35E40Q26252503-C47E3165-00A2-4B76-AD6C-FC007596FDC9Q26271252-DC21840A-8931-4BF2-8F29-EECDAA19821AQ26271255-DA8E7976-35DC-4699-ACA5-06474C8F0CBEQ26749564-1DF84773-912A-48E4-AADE-02FE66D139AAQ26781437-7BCE2E6B-0894-4B60-912A-4E53AF63E01DQ26785329-01A9EC9E-230D-407E-A7EE-25EA8DCC2D73Q26830440-F5CB0E23-EE38-4DA4-AF50-76CDFCCBEF08Q26851900-4B5A5B40-7D09-45C2-AA3D-BFBCBB034EECQ26973002-E8FE3FB0-07AC-45AE-93D7-7E9E976B35DBQ26999739-74A50805-F9D4-47FE-B9AC-75093BC2112BQ27000750-2C8BDAE4-2CFD-4938-9FB2-67F88989E5E3Q27000984-58AA479E-F7B3-4EFF-BE69-01DFD13475F8Q27002608-34730919-7CFF-4EA9-820D-F85AC538E59BQ27011701-A8648B76-B168-4B22-850D-72478FA92CACQ27022471-EA52F989-1646-4B08-83AB-9D8002B867AEQ27860350-B2926223-5ADF-4626-8E4B-BCB1CE800A6AQ27860799-FA7D8DF5-C1C3-48C8-B5B9-7C9E60C82455Q27861941-94AD2654-0D13-44AA-ACE2-30B32BCABBDAQ28005554-A694EE01-E8F3-4024-A21E-55C328F05EF7Q28084924-FE1A8C01-C4E0-4FDF-8683-80611F4EA8FEQ28085661-AF7D9FB4-EA26-400B-B973-E3ADF5DA123FQ28111975-BC7325E5-65EE-4088-AED4-125EC87B718EQ28119353-B1B87580-251D-4094-A4FF-D909DBA5AC56Q28119368-6462B850-DB0E-4F09-B4C8-EACE919F84F0Q28180054-934D7DD2-FB31-499C-8C79-8CB95EFBAA00Q28202080-5F995E5C-EC9E-40F1-BE29-ED5269F21DD5Q28206169-C99F242F-3B6A-4DC6-B2F8-2C3E6219B2E4
P1433
Q42989323-4F49A690-BBAD-49DE-8EA0-789758BFC759Q42992036-BEA5095A-9949-4483-A417-6863707E37C7Q43039127-A71791AB-EC1A-4D3E-BAF8-C4F11218CD74Q43047854-B46C2C70-DAE8-4ED0-A5C0-FE57ED8B068CQ43488767-F4464CEB-F403-4779-95A1-A0A663211047Q43820742-51EF4D4F-6A1F-4758-B20F-D7203422C8AEQ43964781-F866BF80-FA72-4912-B7EA-BC37DD3BFD40Q44094913-B09D0F75-F414-49EE-A174-521B17B59C70Q44103505-28D5ABB1-283F-4F0C-909C-8D6018823E8CQ44118865-2FEEED2D-382E-457A-B42E-84C46EB977BDQ44327809-7E76DF0E-8EC3-4ACA-83B6-B64273027CC1Q44603597-A4AF713C-293A-4B18-9723-C269602D4144Q44651525-92ACB2D2-57D6-4E9C-977F-D7252D82DECBQ44671840-A06B570F-0CF5-4A29-99F0-3F200F2376B8Q44680938-73B2A193-5C17-4BB8-B4E6-B3566935F591Q44715707-F41A465C-8136-4A2C-9F73-095351BAB7BBQ44739127-F94B3809-95FA-4147-A975-BD9769E66B27Q44972448-B4C2BF5E-2CD4-451F-B4FC-EC9ED49FDF56Q45020955-0A8C4C86-138B-452E-8BD8-4E71AD3E48C5Q45963757-9FE803C0-36FB-4CFA-B910-5C5AB1ABFB48Q46333212-06B5E8A8-9842-4193-8068-10097D2EADDFQ46869232-95569782-1435-4038-874E-85B066710500Q47974524-DAF2ACAC-2966-432F-92E0-1C7E5BBFA5D8Q47981668-D7450E93-EF94-4CC1-8835-75EC41A20652Q47992847-CB33EFEF-9F31-4876-8187-9C12F7945D20Q48356840-B16F8538-D401-4364-9125-22B6BBC7FC44Q48574029-D3D2E6D2-BD37-443D-949A-DFC794ADF041Q48604947-3689642C-63B6-491F-8773-0C9E0D553E84Q49650347-2788DE60-229C-4634-AD69-85AEDFA93A83Q50112609-20E37679-684E-49C6-9155-E3B5082DB11AQ50140273-872A8DC2-749E-4D93-9ACA-22F5C6232E00Q50168377-2BF5D22A-0551-4683-91E5-3BE82AAF9367Q50174280-5AB7C5C3-AC7B-4D34-91DE-8FF29CF9973EQ51072160-BA4957A3-5873-49CC-9B48-09614C0B94D2Q51680224-1E30D382-E183-4576-B6B2-71760DA98F4BQ51790140-5191C72C-8752-4003-8CFB-0D85DEA98EE3Q51792654-2B451901-96F7-4168-8C75-0DB620DBC819Q51811910-98DB3AF8-D23D-4746-BD0F-2FA0A1DDC718Q53807999-D839E11B-23C9-4999-88D5-79CF160C88ACQ53818783-97D1A2EE-5629-46B0-BF56-D8EA07770775
P50
description
journal
@en
publikation
@de
revista científica
@es
rivista scientifica
@it
vědecký časopis
@cs
wetenschappelijk tijdschrift van Elsevier
@nl
مجلة
@ar
वैज्ञानिक पत्रिका
@hi
name
The Lancet Infectious Diseases
@ast
The Lancet Infectious Diseases
@da
The Lancet Infectious Diseases
@de
The Lancet Infectious Diseases
@en
The Lancet Infectious Diseases
@es
The Lancet Infectious Diseases
@fi
The Lancet Infectious Diseases
@fr
The Lancet Infectious Diseases
@it
The Lancet Infectious Diseases
@nb
The Lancet Infectious Diseases
@nl
type
label
The Lancet Infectious Diseases
@ast
The Lancet Infectious Diseases
@da
The Lancet Infectious Diseases
@de
The Lancet Infectious Diseases
@en
The Lancet Infectious Diseases
@es
The Lancet Infectious Diseases
@fi
The Lancet Infectious Diseases
@fr
The Lancet Infectious Diseases
@it
The Lancet Infectious Diseases
@nb
The Lancet Infectious Diseases
@nl
altLabel
Lancet Infectious Diseases
@en
prefLabel
The Lancet Infectious Diseases
@ast
The Lancet Infectious Diseases
@da
The Lancet Infectious Diseases
@de
The Lancet Infectious Diseases
@en
The Lancet Infectious Diseases
@es
The Lancet Infectious Diseases
@fi
The Lancet Infectious Diseases
@fr
The Lancet Infectious Diseases
@it
The Lancet Infectious Diseases
@nb
The Lancet Infectious Diseases
@nl
P3181
P4616
P1055
P1058
P1156
P123
P1250
P1277
P1476
The Lancet Infectious Diseases
@en
P236
P407
P5008
P571
2001-01-01T00:00:00Z